Matches in Wikidata for { <http://www.wikidata.org/entity/Q89510829> ?p ?o ?g. }
- Q89510829 description "article scientifique publié en 2020" @default.
- Q89510829 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q89510829 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89510829 description "scientific article published on 28 January 2020" @default.
- Q89510829 description "wetenschappelijk artikel" @default.
- Q89510829 description "наукова стаття, опублікована 28 січня 2020" @default.
- Q89510829 name "Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)" @default.
- Q89510829 name "Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)" @default.
- Q89510829 type Item @default.
- Q89510829 label "Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)" @default.
- Q89510829 label "Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)" @default.
- Q89510829 prefLabel "Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)" @default.
- Q89510829 prefLabel "Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)" @default.
- Q89510829 P1433 Q89510829-1158D414-035E-4288-8991-4853ED1EB54D @default.
- Q89510829 P1476 Q89510829-C71423E3-6314-44DE-BC07-D32DB2803099 @default.
- Q89510829 P2093 Q89510829-08BE2790-F25F-4BF3-8191-4719EE6FCF02 @default.
- Q89510829 P2093 Q89510829-34374447-D8F7-4C12-9DD5-BC96EE9A9AE4 @default.
- Q89510829 P2093 Q89510829-4247FBBC-C31E-46EA-B8E7-06C2F037587A @default.
- Q89510829 P2093 Q89510829-43A9CAE2-210C-4812-A528-223691453463 @default.
- Q89510829 P2093 Q89510829-46D43767-B6DD-4A87-8F0D-F3B9F7844239 @default.
- Q89510829 P2093 Q89510829-65AB54C2-4D9F-49B1-B7B7-2D64F126835C @default.
- Q89510829 P2093 Q89510829-86A21A33-B3A8-4F77-ACE6-EFCC56BFB8FC @default.
- Q89510829 P2093 Q89510829-8ADFA6D4-44A6-437C-8AF2-7A9264FB7D76 @default.
- Q89510829 P2093 Q89510829-8F3AE6DE-87F2-4D17-B2B0-2A4D9C2CC0B0 @default.
- Q89510829 P2093 Q89510829-98C0BABB-2E61-44D7-B140-C7AC16592465 @default.
- Q89510829 P2093 Q89510829-A4C4C16A-6116-40C9-AEA6-E69959FA06BF @default.
- Q89510829 P2093 Q89510829-A9361B88-B685-4DB6-B906-4987027D4835 @default.
- Q89510829 P2093 Q89510829-ABFB0A6B-5F23-4466-B16D-1DF2F5E72519 @default.
- Q89510829 P2093 Q89510829-CBD5EE59-BDE3-429F-A862-76145FFDEEE9 @default.
- Q89510829 P2093 Q89510829-CEFE3DD1-8EDF-4489-8388-F13A725253DC @default.
- Q89510829 P2093 Q89510829-D2FC7056-17B8-40DA-A5EB-532EEC1ADF86 @default.
- Q89510829 P2093 Q89510829-D805DC59-EE2E-4C45-94B7-6C55A037467E @default.
- Q89510829 P2093 Q89510829-E615D40D-45F6-4650-9C60-8E66534B25A9 @default.
- Q89510829 P2093 Q89510829-E7AE5A03-86B7-455F-A699-0035F7537723 @default.
- Q89510829 P2093 Q89510829-F58B6528-1256-4746-88AA-D1C0CB70BA0C @default.
- Q89510829 P2093 Q89510829-F672FD36-5F69-40AB-809C-8457AABD9651 @default.
- Q89510829 P2093 Q89510829-FE3B0B71-E4E6-43B0-A799-B6AB1B2F2919 @default.
- Q89510829 P275 Q89510829-e08f86c8-f398-4e15-92be-e4e9ca4afa14 @default.
- Q89510829 P2860 Q89510829-0105A0A8-4838-421E-8949-53A18445FC6F @default.
- Q89510829 P2860 Q89510829-080DF82B-D6B0-4278-BC06-06CC93C9E328 @default.
- Q89510829 P2860 Q89510829-096FE6A5-C7DE-45ED-BCC0-DCB85ACAFD1C @default.
- Q89510829 P2860 Q89510829-0D8892C6-C642-4AD7-A3B0-A3AA38910BAF @default.
- Q89510829 P2860 Q89510829-273A71B4-BE93-426B-804C-47BA40739437 @default.
- Q89510829 P2860 Q89510829-6FFD0844-BD0F-4553-B6FB-227A1C86A770 @default.
- Q89510829 P2860 Q89510829-747A0EB2-584B-46A3-A980-415417279745 @default.
- Q89510829 P2860 Q89510829-7C1FC060-138F-45C9-88C6-523F3E80E3DA @default.
- Q89510829 P2860 Q89510829-7C66183E-417C-42EA-A875-3D971C07A038 @default.
- Q89510829 P2860 Q89510829-9250F19F-014F-4415-977A-3BCDBC52DDD9 @default.
- Q89510829 P2860 Q89510829-A70C0A6D-D949-4144-B510-C0C2F8F018A0 @default.
- Q89510829 P2860 Q89510829-AA2E84C3-6941-42DE-876F-157379320354 @default.
- Q89510829 P2860 Q89510829-AE114920-551C-432E-A060-2AA293B3DD5C @default.
- Q89510829 P2860 Q89510829-BC9354D6-1B0E-460A-AF8A-D27F4539A207 @default.
- Q89510829 P2860 Q89510829-C0B41D68-3EC0-4481-826C-328D2AE4DAC8 @default.
- Q89510829 P2860 Q89510829-C0DE3F11-C4D0-4D53-8356-60A5BDDAE4F4 @default.
- Q89510829 P2860 Q89510829-C1874EDA-7C5F-4BB9-B74E-C3702D954DFE @default.
- Q89510829 P2860 Q89510829-CA463C44-C157-4124-B5A9-307EA9C078B8 @default.
- Q89510829 P2860 Q89510829-CC06026D-863D-4460-A9C3-5332C877F290 @default.
- Q89510829 P2860 Q89510829-D26628D8-6B80-436B-8FD6-79FD402A9F67 @default.
- Q89510829 P2860 Q89510829-DC6F794C-787C-4543-9E83-58837752F5C9 @default.
- Q89510829 P2860 Q89510829-EC037A39-9056-4CD4-BB4D-A1CE9C57EAC0 @default.
- Q89510829 P2860 Q89510829-ED998E25-BA6F-4A78-902B-0836B7969ADA @default.
- Q89510829 P31 Q89510829-5F3BDC9C-85C6-49D7-A522-24B8E7C34230 @default.
- Q89510829 P356 Q89510829-F4B29E14-917E-41A0-AC72-2A9F4B604933 @default.
- Q89510829 P433 Q89510829-A1D81A9A-3954-4131-A77C-FFDCA71257FB @default.
- Q89510829 P478 Q89510829-F85943F2-5810-4EEF-AE58-675B8A68E783 @default.
- Q89510829 P50 Q89510829-28E6FD78-FB63-49D0-A555-0A4E65986573 @default.
- Q89510829 P50 Q89510829-E69955D8-09E5-4A64-9ACE-797682972DCA @default.
- Q89510829 P577 Q89510829-837EB804-01F5-4286-925B-80461AA1C9BD @default.
- Q89510829 P6216 Q89510829-eebc7d63-4d07-4688-a892-e405d0be10a2 @default.
- Q89510829 P698 Q89510829-0F9E8ADC-1FE7-4B52-96E6-76B8ACEB7266 @default.
- Q89510829 P921 Q89510829-2127EBBB-84CF-4D2E-B47E-FE4486D34B3A @default.
- Q89510829 P921 Q89510829-D0C92276-99B5-4B09-96D4-25B496E5FF18 @default.
- Q89510829 P932 Q89510829-0768BE36-1B63-4E5C-9D99-21E07D5E7BD5 @default.
- Q89510829 P356 CANCERS12020309 @default.
- Q89510829 P698 32013055 @default.
- Q89510829 P1433 Q27722963 @default.
- Q89510829 P1476 "Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)" @default.
- Q89510829 P2093 "Alberto Garaventa" @default.
- Q89510829 P2093 "Andrew D J Pearson" @default.
- Q89510829 P2093 "Cormac Owens" @default.
- Q89510829 P2093 "Dominique Valteau-Couanet" @default.
- Q89510829 P2093 "Ellen Ruud" @default.
- Q89510829 P2093 "Genevieve Laureys" @default.
- Q89510829 P2093 "Godfrey Chi Fung Chan" @default.
- Q89510829 P2093 "Guenter Schreier" @default.
- Q89510829 P2093 "Hans Loibner" @default.
- Q89510829 P2093 "Henrik Schroeder" @default.
- Q89510829 P2093 "Holger N Lode" @default.
- Q89510829 P2093 "Jean Marie Michon" @default.
- Q89510829 P2093 "Keith Holmes" @default.
- Q89510829 P2093 "Maria Rita Castellani" @default.
- Q89510829 P2093 "Mark N Gaze" @default.
- Q89510829 P2093 "Penelope Brock" @default.
- Q89510829 P2093 "Peter Ambros" @default.
- Q89510829 P2093 "Roberto Luksch" @default.
- Q89510829 P2093 "Ruth Ladenstein" @default.
- Q89510829 P2093 "Shifra Ash" @default.
- Q89510829 P2093 "Toby Trahair" @default.
- Q89510829 P2093 "Victoria Castel" @default.
- Q89510829 P275 Q20007257 @default.